相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of developmental exposure to ethanol on Caenorhabditis elegans
Justin R. Davis et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Clozapine and high-dose olanzapine in refractory early-onset schizophrenia: A 12-week randomized and double-blind comparison
Sanjiv Kumra et al.
BIOLOGICAL PSYCHIATRY (2008)
Smoking and schizophrenia: Epidemiological and clinical features
A. Dervaux et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2008)
Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway
R. R. Girgis et al.
MOLECULAR PSYCHIATRY (2008)
The evolution of drug development in schizophrenia: Past issues and future opportunities
William T. Carpenter et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Insulin and insulin-like growth factor-1 abnormalities in anti psychotic-naive schizophrenia
Ganesan Venkatasubramanian et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Antipsychotic drugs disrupt normal development in Caenorhabditis elegans via additional mechanisms besides dopamine and serotonin receptors
Dallas R. Donohoe et al.
PHARMACOLOGICAL RESEARCH (2006)
Activated AKT/PKB signaling in C-elegans uncouples temporally distinct outputs of DAF-2/insulin-like signaling
Minaxi S. Gami et al.
BMC DEVELOPMENTAL BIOLOGY (2006)
Worming pathways to and from DAF-16/FOXO
Arnab Mukhopadhyay et al.
EXPERIMENTAL GERONTOLOGY (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Prevalence of the metabolic syndrome among patients receiving clozapine
J. Steven Lamberti et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction
Zhong Zhao et al.
SCHIZOPHRENIA RESEARCH (2006)
DAF-16/FOXO regulates transcription of cki-1/Cip/Kip and repression of lin-4 during C. elegans L1 arrest
LR Baugh et al.
CURRENT BIOLOGY (2006)
The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia
HO Kalkman
PHARMACOLOGY & THERAPEUTICS (2006)
Fluoxetine-resistance genes in Caenorhabditis elegans function in the intestine and may act in drug transport
RKM Choy et al.
GENETICS (2006)
Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia
Xiaoduo Fan et al.
SCHIZOPHRENIA RESEARCH (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Systematic analysis of genes required for synapse structure and function
D Sieburth et al.
NATURE (2005)
Modern antipsychotic drugs: a critical overview
DM Gardner et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16
SW Oh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span
M Hertweck et al.
DEVELOPMENTAL CELL (2004)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine
DM Weiner et al.
PSYCHOPHARMACOLOGY (2004)
A central role of the BK potassium channel in behavioral responses to ethanol in C-elegans
AG Davies et al.
CELL (2003)
N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity
C Sur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression profiling of cells, tissues, and developmental stages of the nematode C-elegans
SJ McKay et al.
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY (2003)
microRNAs: Tiny regulators with great potential
V Ambros
CELL (2001)
Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms
G Sesti et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2001)
Incidence of cancer among persons with schizophrenia and their relatives
D Lichtermann et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C-elegans insulin gene family
SB Pierce et al.
GENES & DEVELOPMENT (2001)
A five-year longitudinal study of the regional cerebral metabolic changes of a schizophrenic patient from the first episode using Tc-99m HMPAO SPECT
RYL Chen et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2000)
分享论文
